Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen ROIVANT SCIENCES LTD stake
total: 670
Viking Global Investors ROIV trades
- Total transactions:
- 13
- New positions:
- 1
- Added:
- 1
- Reduced:
- 11
- Held since:
- 2021 Q4
- Held for:
- 19 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen holds 6,271,467 ROIVANT SCIENCES LTD (ROIV) shares with a market value of roughly $221.95M accounting for 0.63% of the overall portfolio. To date, the estimated cost basis is nearly $10.12 for "buy" trades and estimated average "sell" price is $13.94. Viking Global Investors first purchased ROIV in 2021 Q4, initially acquiring about 88.24M shares. Since the initial investment in ROIVANT SCIENCES LTD (ROIV), Viking Global Investors has made 12 more transactions.
When did Ole Andreas Halvorsen buy ROIVANT SCIENCES LTD (ROIV)?
Ole Andreas Halvorsen first invested in ROIVANT SCIENCES LTD (ROIV) in 2021 Q4 at the reported quarter-end price of $10.08 per share.
What's the cost basis of Viking Global Investors's ROIV stake?
The estimated cost basis for ROIVANT SCIENCES LTD (ROIV) stake is around $10.12 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.12
- Weighted AVG sell price:
- $13.94
Ole Andreas Halvorsen's historical trades in ROIVANT SCIENCES LTD
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.63%
|
6,271,467
|
$35.39
|
$221,947,217
|
-5.73% (-380,981)
|
-0.04%
|
|
2026 Q1
|
0.52%
|
6,652,448
|
$27.70
|
$184,272,810
|
+3.25% (+209,257)
|
+0.02%
|
|
2025 Q4
|
0.37%
|
6,443,191
|
$21.70
|
$139,817,245
|
-72.69% (-17,151,640)
|
-0.97%
|
|
2025 Q3
|
0.93%
|
23,594,831
|
$15.13
|
$356,989,793
|
-31.09% (-10,642,948)
|
-0.47%
|
|
2025 Q2
|
1.12%
|
34,237,779
|
$11.27
|
$385,859,769
|
-25.59% (-11,775,973)
|
-0.42%
|
|
2025 Q1
|
1.48%
|
46,013,752
|
$10.09
|
$464,278,758
|
-3.76% (-1,796,208)
|
-0.06%
|
|
2024 Q4
|
1.83%
|
47,809,960
|
$11.83
|
$565,591,827
|
-11.63% (-6,289,106)
|
-0.27%
|
|
2024 Q3
|
2.28%
|
54,099,066
|
$11.54
|
$624,303,222
|
-21.77% (-15,056,780)
|
-0.67%
|
|
2024 Q2
|
2.81%
|
69,155,846
|
$10.57
|
$730,977,292
|
-0.31% (-213,115)
|
-0.01%
|
|
2023 Q4
|
2.85%
|
69,368,961
|
$11.23
|
$779,013,432
|
-5.54% (-4,065,340)
|
-0.19%
|
|
2023 Q3
|
3.48%
|
$11.68
|
-2.40% (-1,804,399)
|
|||
|
2023 Q2
|
3.10%
|
$10.08
|
-14.73% (-13,000,000)
|
|||
|
2021 Q4
|
2.56%
|
$10.08
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.